About NuVasive
NuVasive is a company based in San Diego (United States) founded in 1997 was acquired by Globus Medical in February 2023.. NuVasive has raised $54.1 million across 5 funding rounds from investors including Kleiner Perkins, Globus Medical and Johnson & Johnson Innovation – JJDC. NuVasive has completed 7 acquisitions, including Biotronic, Ellipse Technologies and Globus Medical. NuVasive offers products and services including XLIF, C360, P360, and Pulse. NuVasive operates in a competitive market with competitors including Stryker, Ensoma, In'Tech Medical, CARLSMED and Orthofix, among others.
- Headquarter San Diego, United States
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$54.1 M (USD)
in 5 rounds
-
Latest Funding Round
$400 M (USD), Post-IPO
May 26, 2020
-
Investors
Kleiner Perkins
& 6 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Biotronic
& 6 more
-
Acquired by
Globus Medical
(Feb 09, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NuVasive
NuVasive offers a comprehensive portfolio of products and services, including XLIF, C360, P360, and Pulse. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Minimally invasive lateral lumbar fusion technique
Integrated solutions for anterior and posterior procedures
Techniques for open and less-invasive posterior surgeries
Platform to enhance surgical workflows and outcomes
Unlock access to complete
Unlock access to complete
Software Development Team
159 people
Leadership Team
66 people
Sales and Marketing
61 people
Product Management Team
41 people
Spine Team
21 people
Senior Team
15 people
Legal and Compliance
9 people
Operations Team
7 people
Unlock access to complete
Funding Insights of NuVasive
NuVasive has successfully raised a total of $54.1M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $400 million completed in May 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $400.0M
-
First Round
First Round
(22 May 2001)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2020 | Amount | Post-IPO - NuVasive | Valuation |
investors |
|
| Oct, 2011 | Amount | Post-IPO - NuVasive | Valuation |
investors |
|
| Jun, 2003 | Amount | Series D - NuVasive | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NuVasive
NuVasive has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Kleiner Perkins, Globus Medical and Johnson & Johnson Innovation – JJDC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm backed by Johnson & Johnson
|
Founded Year | Domain | Location | |
|
VC firm focusing on life science sector
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in early-stage tech startups
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NuVasive
NuVasive has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Biotronic, Ellipse Technologies and Globus Medical. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Globus Medical is engaged in developing innovative medical devices for spine and orthopedic solutions.
|
2013 | ||||
|
Develops fusion devices using patented porous PEEK technology
|
2013 | ||||
|
Low-radiation fluoroscopic images are enhanced for better resolution and contrast.
|
2012 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - NuVasive
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nuvasive Comparisons
Competitors of NuVasive
NuVasive operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Stryker, Ensoma, In'Tech Medical, CARLSMED and Orthofix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
3D-printed orthopedic products are manufactured for medical applications.
|
|
| domain | founded_year | HQ Location |
Provider of in vivo stem cell modification technologies and vector-based drug delivery tool
|
|
| domain | founded_year | HQ Location |
Surgical instruments for orthopaedics are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Developer of devices for spine surgery
|
|
| domain | founded_year | HQ Location |
Reconstructive and regenerative solutions for bone conditions are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nuvasive
Frequently Asked Questions about NuVasive
When was NuVasive founded?
NuVasive was founded in 1997 and raised its 1st funding round 4 years after it was founded.
Where is NuVasive located?
NuVasive is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is NuVasive a funded company?
NuVasive is a funded company, having raised a total of $54.1M across 5 funding rounds to date. The company's 1st funding round was a Series D of $9.8M, raised on May 22, 2001.
What does NuVasive do?
NuVasive was founded in 1997 in San Diego, United States, as a developer of medical devices focused on spinal surgery. Operations include the marketing of seven products, such as the stem cell-based Osteocel, and the NVM5 system for intraoperative neuromonitoring. The company went public in 2012 and acquired Ellipse Technologies, an orthopedic device maker, in January 2016. Activities center on orthopedic innovations in the healthcare sector.
Who are the top competitors of NuVasive?
What products or services does NuVasive offer?
NuVasive offers XLIF, C360, P360, and Pulse.
How many acquisitions has NuVasive made?
NuVasive has made 7 acquisitions, including Biotronic, Ellipse Technologies, and Globus Medical.
Who are NuVasive's investors?
NuVasive has 7 investors. Key investors include Kleiner Perkins, Globus Medical, Johnson & Johnson Innovation – JJDC, William Blair, and Pappas Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.